• Activity INFORMATION

  Overview

  This session is part of the Opioid Module, which explores the safe and effective utilization of prescription opioids within diverse pain management treatment plans during the opioid crisis. This session reviews the additional study category for a medication to not only attain FDA-approval, but to additionally have FDA approval as an abuse deterrent formulation (ADF) prescription opioid medication. This session will review product selection and patient counseling points for the ADF prescription opioids that are FDA approved as an ADF opioid medication and actually available on the U.S. market.
  

  Handouts

  • Slide Document :   22027H08_2pp.pdf Download

  • Slide Document :   22027H08_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Discuss common methods of manipulation of abuse-deterrent formulation (ADF) opioid medications

  Recall the available abuse-deterrent formulation (ADF) opioid medications, with particular attention to the select few that are both FDA approved specifically as ADF opioid medications and available on the U.S. market

  Identify the seven current types of abuse-deterrent formulations

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-879829

  Universal Activity Number

  Pharmacist 0798-0000-22-027-H08-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).